RCMT — RCM Technologies, Inc.

RCM Technologies (RCMT) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Consolidated Gross Profit: $19.4 million, up 8.8% from Q3 2024.
• Adjusted EBITDA: $5.5 million, slightly down 1.4% from $5.6 million in Q3 2024.
• Adjusted EPS: $0.42, unchanged from the prior year.
• Healthcare Segment: Gross profit of $9.0 million (up 8.5% YoY); gross margin decreased to 30.0% from 31.2%.
• Engineering Segment: Gross profit reached $6.9 million (up 17.3% YoY); gross margin declined to 22.0% from 24.4%.
• Life Sciences and Data Solutions: Gross profit of $3.5 million, down 4.2% YoY; gross margin improved to 39.5% from 38.0%.
• Excess Medical Costs: Approximately $1.8 million year-to-date, impacting SG&A expenses.

2. Strategic Updates and Business Highlights

• Healthcare: Strong growth in school partnerships, with Q3 school revenue up 20.7% YoY. Increased penetration in existing clients and a robust recruitment pipeline for foreign nurses.
• Life Sciences: Focus on AI-driven solutions and compliance protocols. A dedicated engineering group is being established to enhance market differentiation.
• Energy Services: Achieved record backlog for 2026, with strong demand for integrated engineering and EPC services. Emphasis on partnerships with Tier 1 utility clients.
• Aerospace and Defense: Revenue growth of nearly 45% YoY, with significant contributions from government contracts and new service areas.

3. Forward Guidance and Outlook

• Q4 Expectations: Anticipated to yield the highest quarterly gross profit and adjusted EBITDA for fiscal 2025. Strong momentum heading into 2026, particularly in healthcare and engineering.
• Long-term Growth: Focus on expanding capabilities in healthcare and exploring new markets, including potential outsourcing in the Philippines.

4. Bad News, Challenges, or Points of Concern

• Medical Costs: Ongoing high medical claims are a concern, with no immediate relief expected in Q4.
• Cash Flow Issues: Disappointment in cash flow from operations due to collection issues with large school clients.
• Competitive Pressures: Increased competition in certain markets, particularly in healthcare, though RCM has maintained market share.
• Industrial Process Segment: Needs strategic adjustments and has not shown significant growth, although it remains stable.

5. Notable Q&A Insights

• Foreign Nurse Recruitment: 300 nurses ready to come over pending visa approvals, with potential impact dependent on visa retrogression.
• Medical Cost Predictions: Difficulty in predicting future medical costs, with inflationary pressures contributing to rising expenses.
• Engineering Segment Margins: Variability in gross margins due to revenue mix and subcontractor reliance.
• Expansion Opportunities: Potential to replicate the successful school model in other areas, such as hospitals and substitute teaching services.

Overall, RCM Technologies demonstrated resilience in Q3 2025, with solid growth metrics despite facing challenges in medical costs and cash flow. The company remains optimistic about future growth driven by strategic investments and market demand.